Gene · 406919
Papers3,220
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,220
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Anti-Aging Effects of Adipose-Derived Mesenchymal Stem Cell Exosomes on Skin and Their Potential for Personalized Skincare Applications. | Clin Cosmet Investig Dermatol | 2025 | 40963883 | PubTator, text mining | PubMed |
| Advances in miRNA research: Unraveling the complexities of gene regulation. | Animal Model Exp Med | 2025 | 40947823 | PubTator, text mining | PubMed |
| Unveiling the immunomodulatory mechanisms of fever-range whole-body hyperthermia in humans: Insights from miRNA and protein mediators. | Int Immunopharmacol | 2025 | 40929957 | PubTator, text mining | PubMed |
| Chemotherapy-induced alterations in miRNA expression and their prognostic implications in ovarian cancer. | Front Oncol | 2025 | 40919157 | PubTator, text mining | PubMed |
| A Liquid Biopsy Assay of Exosomal miRNA for Non-invasive Identification of Lymph Node Metastasis in Early Gastric Cancer. | Ann Surg Oncol | 2025 | 40892283 | PubTator, text mining | PubMed |
| Exosomes in ovarian cancer: Impact on drug resistance and advances in SERS detection techniques. | J Pharm Anal | 2025 | 40757000 | PubTator, text mining | PubMed |
| A novel miRNA-based model for predicting the 3-year recurrence risk of hepatocellular carcinoma following liver transplantation. | J Gastrointest Oncol | 2025 | 40672061 | PubTator, text mining | PubMed |
| Role of Exosomes in Cardiovascular Disease: A Key Regulator of Intercellular Communication in Cardiomyocytes. | ACS Omega | 2025 | 40385188 | PubTator, text mining | PubMed |
| Impact of MiRNAs on Wnt-related gene activity in breast cancer. | Sci Rep | 2025 | 40346182 | PubTator, text mining | PubMed |
| A thematic analysis of prognostic, diagnostic, and therapeutic of circulating miRNA biomarkers in bortezomib-resistant multiple myeloma. | SAGE Open Med | 2025 | 40297788 | PubTator, text mining | PubMed |
| Impact of monotherapy and combination therapy with glucagon-like peptide-1 receptor agonists on exosomal and non-exosomal MicroRNA signatures in type 2 diabetes mellitus: a systematic review. | J Transl Med | 2025 | 40281607 | PubTator, text mining | PubMed |
| Remodeling of Effector and Regulatory T Cells by Capture and Utilization of miRNAs Using Nanocomposite Hydrogel for Tumor-Specific Photothermal Immunotherapy. | ACS Nano | 2025 | 40223522 | PubTator, text mining | PubMed |
| The study of miR-130a expression and its mechanism of action in peripheral blood endothelial progenitor cells (EPCs) in type 2 diabetes mellitus (T2DM). | Sci Rep | 2025 | 40169737 | PubTator, text mining | PubMed |
| Transcriptomic profile induced by calcitriol in CaSki human cervical cancer cell line. | PLoS One | 2025 | 40168262 | PubTator, text mining | PubMed |
| Exploring the role of exosomes in diabetic neuropathy: From molecular mechanisms to therapeutic potential. | Biomed Pharmacother | 2025 | 40056828 | PubTator, text mining | PubMed |
| Specific muscle targeted delivery of miR-130a loaded lipid nanoparticles: a novel approach to inhibit lipid accumulation in skeletal muscle and obesity. | J Nanobiotechnology | 2025 | 40033366 | PubTator, text mining | PubMed |
| Exosomal Biomarkers for Prognosis in Oral Squamous Cell Carcinoma-A Systematic Review of Emerging Technologies. | J Craniofac Surg | 2025 | 40009435 | PubTator, text mining | PubMed |
| Integrated analysis of non‑coding RNAs (HOTAIR and miR‑130a) and their cross‑talk with TGF‑β1, SIRT1 and E‑cadherin as potential biomarkers in colorectal cancer. | Oncol Lett | 2025 | 39807105 | PubTator, text mining | PubMed |
| Managing cardiovascular events, hyperglycemia, and obesity in type 2 diabetes through microRNA regulation linked to glucagon-like peptide-1 receptor agonists. | Diabetol Metab Syndr | 2025 | 39794819 | PubTator, text mining | PubMed |
| MicroRNA-199a-5p may be a diagnostic biomarker of primary ITP. | Br J Haematol | 2025 | 39776057 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406919/papers?page=2